The Food and Drug Administration (FDA) is announcing a public Workshop entitled: “Optimizing FDA’s Regulatory Oversight of Next Generation Sequencing Diagnostic Tests.†The purpose of this workshop is to discuss and receive feedback from the community on FDA’s regulatory approach to diagnostic tests for human genetics or genomics using Next Generation Sequencing (NGS) technology.
- Date, Time and Location
- Federal Register Notice
- Discussion Paper
- Agenda
- Registration
- Contact Us
Date, Time and Location:
This meeting will be held February 20, 2015, from 8:30 am to 5:00 pm. at the following location:
Natcher Center at the NIH Campus
9000 Rockville Pike
Bldg. 45, Auditorium
Bethesda, MD 20814
NIH Campus Visitor Information
The meeting will be webcast (registration required).
[email protected] at least 7 days in advance of the meeting.
[email protected].
For questions regarding workshop content please contact:
David Litwack, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Bldg. 66, rm. 5544, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-6697, email: [email protected].
Â